Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Adverse Event”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03988790
What this trial is testing

Evaluation of the Response to Monoclonal Antibody Therapy in Severe Asthma: Research of Predictive Biomarkers in Exhaled Air

Who this might be right for
Asthma
Hopital Foch 50
Not applicableLooking for participantsNCT07706413
What this trial is testing

Plasma Exchange in Children With Severe Sepsis and Septic Shock

Who this might be right for
Severe Sepsis
Menoufia University 22
Not applicableStudy completedNCT04241874
What this trial is testing

PEEP and Spontaneous Breathing During ARDS

Who this might be right for
Acute Respiratory Distress Syndrome
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 16
Large-scale testing (Phase 3)Study completedNCT02441218
What this trial is testing

Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study

Who this might be right for
Chronic Heart Failure
Institut de Recherches Internationales Servier 6,505
Not applicableLooking for participantsNCT06072690
What this trial is testing

Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease ModerateChronic Obstructive Pulmonary Disease SevereCardiovascular Diseases+1 more
Lithuanian University of Health Sciences 80
Not applicableNot Yet RecruitingNCT07057713
What this trial is testing

Total Arterial vs. Mixed Grafting in Left Coronary CABG

Who this might be right for
Coronary Artery DiseaseCoronary Artery Bypass GraftingArterial Graft+2 more
Second Hospital of Jilin University 400
Very early researchLooking for participantsNCT07614191
What this trial is testing

A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate to Severe Refractory Autoimmune Diseases

Who this might be right for
Moderate to Severe Refractory Autoimmune Diseases
Vivacta Biotechnology (Shanghai) Co., Ltd. 22
Testing effectiveness (Phase 2)Study completedNCT04877990
What this trial is testing

Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis

Who this might be right for
Crohn DiseaseUlcerative Colitis
Bristol-Myers Squibb 67
Not applicableStudy completedNCT04425213
What this trial is testing

Obesity and Mortality of Critically Ill Patients With COVID-19

Who this might be right for
COVIDSevere Acute Respiratory SyndromeObesity+1 more
Central Hospital, Nancy, France 250
Not applicableWithdrawnNCT02598674
What this trial is testing

Severe Sepsis in Children - IMPRESS-C

Who this might be right for
Acute Kidney InjuryChronic Kidney DiseaseHypertension
University of Florida
Not applicableUnknownNCT02457013
What this trial is testing

Interest of High Flow Nasal Cannula (HFNC) Versus Non Invasive Ventilation During the Initial Management of Severe Bronchiolitis in Infants

Who this might be right for
Bronchiolitis
University Hospital, Montpellier 142
Not applicableStudy completedNCT04874974
What this trial is testing

Feasibility of a Novel Process-based Treatment for Patients With Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderDelusional Disorder+10 more
Max-Planck-Institute of Psychiatry 37
Not applicableStudy completedNCT07777497
What this trial is testing

Respiratory Therapist-Supported Home Noninvasive Ventilation in Stable Severe COPD Without Hypercapnia

Who this might be right for
COPD
Kaohsiung Medical University Chung-Ho Memorial Hospital 14
Not applicableStudy completedNCT00001990
What this trial is testing

An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
Glaxo Wellcome
Large-scale testing (Phase 3)Study completedNCT05407597
What this trial is testing

Inhibition of Bradykinin in COVID-19 Infection With Icatibant

Who this might be right for
SARS CoV 2 Infection
Belfast Health and Social Care Trust 32
Not applicableStudy completedNCT02888197
What this trial is testing

Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization

Who this might be right for
Candidiasis, VulvovaginalYeast InfectionMycoses+2 more
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 32
Large-scale testing (Phase 3)UnknownNCT00791310
What this trial is testing

Evaluation of MorphoTEP With the FDG Among Patients in Severe Sepsis of Unspecified Etiology

Who this might be right for
Severe Sepsis
Central Hospital, Nancy, France 30
Not applicableLooking for participantsNCT00903110
What this trial is testing

Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Who this might be right for
IGF1 Deficiency
Esteve Pharmaceuticals, S.A. 500
Not applicableUnknownNCT04813510
What this trial is testing

Effect of Electroacupuncture on SAP With MODS

Who this might be right for
Severe Acute Pancreatitis
Jianbo Yu 110
Not applicableLooking for participantsNCT06988618
What this trial is testing

Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

Who this might be right for
Prurigo Nodularis
Galderma R&D 600
Next Page